Deletion of the inhibitory co-receptor CTLA-4 enhances and invigorates chimeric antigen receptor T cells-Reference-Cited by-同舟云学术

Deletion of the inhibitory co-receptor CTLA-4 enhances and invigorates chimeric antigen receptor T cells

Published:2023-10 Issue:10 Volume:56 Page:2388-2407.e9
ISSN:1074-7613
Container-title:Immunity
language:en
Short-container-title:Immunity

Author:

Agarwal Sangya,Aznar M. Angela,Rech Andrew J.,Good Charly R.,Kuramitsu Shunichiro,Da Tong,Gohil Mercy,Chen Linhui,Hong Seok-Jae Albert,Ravikumar Pranali,Rennels Austin K.,Salas-Mckee January,Kong Weimin,Ruella Marco,Davis Megan M.,Plesa Gabriela,Fraietta Joseph A.,Porter David L.,Young Regina M.,June Carl H.^ORCID

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference99 articles.

1. Efficacy and Toxicity Management of 19–28z CAR T cell Therapy in B cell Acute lymphoblastic leukemia;Davila;Sci. Transl. Med.,2014

2. Tisagenlecleucel in children and young adults with B-cell lymphoblastic leukemia;Maude;N. Engl. J. Med.,2018

3. KTE-X19 for relapsed or refractory adult B-cell acute lymphoblastic leukaemia: phase 2 results of the single-arm, open-label, multicentre ZUMA-3 study;Shah;Lancet,2021

4. Next-generation CAR T-cell therapies;Young;Cancer Discov.,2022

5. Disease burden affects outcomes in pediatric and young adult B-cell lymphoblastic leukemia after commercial tisagenlecleucel: A pediatric real-world chimeric antigen receptor consortium report;Schultz;J. Clin. Oncol.,2022

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antigen escape in CAR-T cell therapy: Mechanisms and overcoming strategies;Biomedicine & Pharmacotherapy;2024-09

2. Strategies for Improving CAR T Cell Persistence in Solid Tumors;Cancers;2024-08-16

3. CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors;Cellular & Molecular Immunology;2024-08-12

4. Pan-cancer analysis of immune checkpoint receptors and ligands in various cells in the tumor immune microenvironment;Aging;2024-08-07

5. Boosting CAR-T cell therapy with CRISPR technology;hLife;2024-08